Medical Devices
Companies, insights, and experts shaping the future of medical devices.
Companies
11 companies tracked in Medical Devices
Abbott Laboratories
US, Chicago
Becton Dickinson
US, Franklin Lakes
Boston Scientific
US, Marlborough
Edwards Lifesciences
US, Irvine
Intuitive Surgical
US, Sunnyvale
Johnson & Johnson
US, New Brunswick
Medtronic
US, Galway
MicroPort
CN, Shanghai
Mindray
CN, Shenzhen
Stryker
US, Kalamazoo
United Imaging
CN, Shanghai
Insights & Analysis
6 insights in Life Sciences
$181/Genome and Falling: Why Genomics' Next Frontier Is Interpretation Equity, Not Sequencing Speed
Hey, I'm Rachel Green. If you think my obsession with sequencing costs borders on pathological â you're right, it does. But when you've tracked $/genome data for fifteen years and watched it fall from...
da Vinci 5 Cuts Console Time by 18%: The Data Behind Medtech's AI and Robotics Revolution and Its Safety Gaps
I'm Ahmed Hassan. After nineteen years in engineering R&D for minimally invasive surgical devices at Medtronic, I have arrived at one conviction: the medical device industry has only one valid measure...
Only 11% of AI-Generated Molecules Survived the Lab: Why AI Drug Discovery Needs an Evidence Reckoning
Hello, I'm Wei Zhang. After leaving Recursion Pharmaceuticals, I spent considerable time reflecting on a question: is the AI drug discovery industry creating value, or generating noise? My conclusion...
65% Complete Response at 50 Months: CAR-T's Triumph in Blood Cancers and Its Unfinished Business in Solid Tumors
I'm Hannah Kim. During my years leading CAR-T R&D at Kite Pharma, I developed a habit: when I look at any clinical data, I check safety first, efficacy second, and commercial potential last. Because t...
From 41% to 67% Strain Success Rate: Why Synthetic Biology's Real Bottleneck Isn't What You Think
I'm Marcus Weber. After six years as Chief Scientist at Ginkgo Bioworks, I learned one thing above all: the core question in synthetic biology has never been "can we build it?" â it is "can we build i...
97% VOE-Free at 33 Months: What CRISPR's Longest Follow-Up Data Really Tells Us
Colleagues, I'm Sofia Rodriguez. After a decade in the CRISPR field and postdoctoral training at the Broad Institute, what I hold in deepest reverence about this technology is not what it *can* do â i...
Community Members
2 members interested in Medical Devices
Want deeper intelligence on Medical Devices?
Get access to all reports, company profiles, and real-time market data.